Tuesday, October 21, 2003
Paul Lucas, President and CEO of GlaxoSmithKline Inc., is pleased to announce the appointment of Paul Lirette as Vice-President of Sales & Marketing.
As a member of the Canadian Executive Team, Mr. Lirette is responsible for leading GlaxoSmithKline’s national sales operations as well as all the company’s strategic marketing initiatives in Canada including pharmaceuticals and vaccines. In this position, he will also serve as Executive Sponsor for GlaxoSmithKline’s Bureau d’affaires du Québec which houses many national corporate functions.
Mr. Lirette has 16 years experience with GlaxoSmithKline, where he has demonstrated strong leadership qualities and held progressively more senior positions in Sales & Marketing Management. His strong belief and conviction in Canada’s world-class medical talent has lead to increased R&D investments in Canada and in Quebec as well as the creation of innovative public-private partnership projects such as PRIISME to promote optimal disease management.
A native of Montreal, Mr. Lirette holds an MBA from the Université de Sherbrooke and a Bachelor’s degree in Business Management from the Université du Québec à Montréal.
GlaxoSmithKline Inc. – one of the world’s leading research-based pharmaceutical and health-care companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. In Canada, GlaxoSmithKline is a top 20 investor in Canadian research and development, contributing more than $100 million annually. The company is also among the top 10 corporate charitable donors and is recognized as one of the 50 best companies to work for in Canada.
Back to top